Related Experiment Videos
Is propofol cost-effective for day-surgery patients?
1Department of Anaesthesia, Royal Women's Hospital, Melbourne, Victoria, Australia.
Anaesthesia and Intensive Care
|May 1, 1991
Summary
Propofol offers slight advantages over methohexitone for anesthesia induction in day surgery, showing faster recovery and fewer side effects. However, its higher cost may not justify routine use over methohexitone, making the choice a matter of clinical judgment.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Propofol is a widely used anesthetic agent.
- Methohexitone is another commonly used induction agent for short procedures.
Purpose of the Study:
- To compare the efficacy and patient outcomes of propofol versus methohexitone for anesthesia induction in day surgery.
- To evaluate the cost-effectiveness of propofol in this setting.
Main Methods:
- A randomized controlled trial involving 70 healthy patients undergoing elective minor gynecological procedures.
- Patients received either propofol or methohexitone for anesthesia induction.
- Postoperative recovery times, side effects, and patient satisfaction were assessed.
Main Results:
- Propofol demonstrated statistically significant improvements in response time and ambulation time compared to methohexitone.
- Fewer instances of vomiting and drowsiness were observed in the propofol group during recovery.
- Patient appraisal the following day showed only minor differences between the two agents.
Conclusions:
- While propofol offers some benefits in terms of faster recovery and reduced side effects, these advantages may not be substantial enough to justify its higher expense for routine use in day surgery.
- The decision to use propofol over methohexitone should be based on individual clinical judgment and patient-specific factors.